NAMS
NASDAQ · Biotechnology
Newamsterdam Pharma Co Nv
$31.40
+0.58 (+1.88%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-10.97%
1Y
+70.65%
YTD
-10.80%
Open$30.58
Previous Close$30.82
Day High$31.49
Day Low$30.31
52W High$42.21
52W Low$17.63
Volume—
Avg Volume1.04M
Market Cap3.49B
P/E Ratio—
EPS$-1.77
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$34.11
Below
SMA 200
$28.53
Above
RSI (14)
66.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
22 analysts
Price Target
+15.9% upside
Current
$31.40
$31.40
Target
$36.39
$36.39
$23.00
$36.39 avg
$47.36
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 22.21M | 36.21M | 2.72B |
| Net Income | -201,203,432 | -295,212,078 | 249.35M |
| Profit Margin | -905.7% | -860.5% | 9.2% |
| EBITDA | -222,573,479 | -344,709,496 | 355.91M |
| Free Cash Flow | — | — | 147.67M |
| Rev Growth | -38.7% | -38.7% | +24.9% |
| Debt/Equity | — | — | 0.72 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |